2021
|
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
|
|
LNJP
|
|
|
Sir Gangaram
|
|
|
AIIMS
|
|
|
Apollo
|
Detailed explanation-1: -Phase 1 and Phase 2 clinical trialsconducted in 755 participants demonstrated high safety profile of the candidate vaccine withseroconversion rates of 98.3% and 81.1%on day 56 and 104respectively.
Detailed explanation-2: -SAGE has thoroughly assessed the data on safety and efficacy of the vaccine and has recommended its use for people aged 18 and above.
Detailed explanation-3: -COVAXIN® has been approved for restricted use in emergency situation in individuals 18 years of age and older.
Detailed explanation-4: -COVID vaccination in the country commenced with vaccination to all Health Care Workers. The program was expanded with time to include vaccination of Front Line Workers, citizens more than 60 years of age, citizens more than 45 years of age, and eventually citizens more than 18 years of age.